By a News Reporter-Staff News Editor at Biotech Business Week -- CytoDyn Inc. ("CytoDyn") (OTC QB: CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced that A. Bruce Montgomery, M.D. has been appointed to the board of directors effective September 27, 2013 (see also CytoDyn Inc.).
Dr. Montgomery is a prominent biotech entrepreneur with an extensive background in product development and clinical studies, currently holding the position of Chief Executive Officer of Cardeas Pharma Corporation. Before joining Cardeas Pharma Corporation in 2010, Dr. Montgomery founded and was the Chief Executive Officer of Corus Pharma, Inc., a development stage pharmaceutical company, from 2001 until 2006. In 2006, Gilead acquired Corus Pharma, Inc., and Dr. Montgomery continued at Gilead, serving as Senior Vice President, Respiratory Therapeutics, from 2006 until 2010. Additionally, he previously held positions in clinical development with PathoGenesis Corporation and Genentech.
Dr. Montgomery is a board member of Alder Biotherapeutics and a Trustee for the Washington State Life Sciences Discovery Fund. He has previously served on the boards of ZymoGenetics, Inc., Pacific Science Center, and the Washington State Biotechnology BioMedical Association. Dr. Montgomery received a B.S. degree in chemistry and his M.D. from the University of Washington, and completed his residency in Internal Medicine at the University of Washington and fellowships at the University of Washington and the University of California, San Francisco.
"The Company welcomes Dr. Montgomery to our board of directors," said Nader Pourhassan, CytoDyn's President and CEO. "His extensive pharmaceutical research, development and patent experience, as well as his skills in fundraising and entrepreneurship, will help propel CytoDyn in future endeavors."
Keywords for this news article include: CytoDyn Inc.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC